Scalper1 News
Shares of generic drugmaker Lannett (LCI) climbed 7% on the stock market today, clearing a cup base buy point. Industry group peer Akorn (AKRX) cleared an area of consolidation earlier this month. For details on Lannett’s buy range, and other information about this top-rated stock, make sure to check out this video. Follow Alissa Williams on Twitter: @IBD_AWilliams. Scalper1 News
Scalper1 News